At a glance
ClinicalIndex Comparison RecordN/ACompleted· 97 enrolled
Drug / intervention
Intensified Treatment of risk factorsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multifactorial Treatment of Cardiovascular Risk in Patients With Diabetes Mellitus Type-2: Identification of Treatment Non-Responders (The CARDIONOR Study)
In Brief
An observational study evaluating Intensified Treatment of risk factors for Diabetes Mellitus, Type II. Completed, enrolled 97 participants across 1 site.
Detailed Summary
The aim of the study is to develop a model that allows early identification of type-2 diabetic patients who will face progressive atherosclerosis despite intensive, multifactorial, target oriented treatment
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type II
CountriesAustria
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
First PostedApr 2008
Primary CompletionJul 2012
TodayJul 2026
First PostedApr 17, 2008
Enrollment StartApr 1, 2008
Primary CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 18.2 years ago
Interventions
Intensified Treatment of risk factorsother
Patients received a target oriented, intensified treatment of risk factors according to current national treatment guidelines